Enzymatica AB
Develops medical devices for infections based on a proprietary marine enzyme technology.
ENZY | ST
Overview
Corporate Details
- ISIN(s):
- SE0003943620 (+4 more)
- LEI:
- 529900HNJP0335URJQ76
- Country:
- Sweden
- Address:
- Ideon Science Park, 223 70 Lund
- Website:
- https://www.enzymatica.se/
- Sector:
- Manufacturing
Description
Enzymatica AB is a life science company that develops and sells medical devices for infection-related diseases. The company's products are based on a proprietary barrier technology that utilizes a marine enzyme to form a protective layer in the mouth and throat. This barrier deactivates viruses and supports the body's natural defenses against microorganisms. Its primary product, ColdZyme®, is an oral spray designed to help prevent common colds and can shorten the duration of symptoms by targeting the underlying cause of the infection.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Enzymatica AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Enzymatica AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Enzymatica AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-12 | Helene Willberg | Other | Buy | 48,000 | 147,840.00 SEK |
Peer Companies
